Author
Thomas Burke
University of California, IrvineORCID 0000-0002-1385-8757Unclaimed ORCID profile · follow to get notified of new preprints
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2024-2026 · peak 3/yrCo-Author Collaboration Network
10 top collaborators · 7 mutual co-author links5 papers
Recent·Most cited
- MicrobiologybioRxivPreprintDOI 10.64898/2026.06.12.731980
- MicrobiologybioRxivPreprint
Host cyclophilin-mediated maturation of an obligate intracellular bacterial surface virulence factor
Brandon Sit, Allen G. Sanderlin, Alejandro A. Guzman…·Rebecca L. Lamason
This study identifies cyclophilin A as a host factor critical for the maturation and function of a virulence factor in obligate intracellular bacteria, with implications for therapeutic targeting.
1 citation - MicrobiologyPLoS PathogensPeer-reviewed
Comparative virulence analysis of seven diverse strains of Orientia tsutsugamushi reveals a multifaceted and complex interplay of virulence factors responsible for disease.
Panjaporn Chaichana, Naphat Satapoomin, Chitrasak Kullapanich…·Jeanne Salje
This study compares seven strains of Orientia tsutsugamushi to identify virulence factors, finding no single gene or pattern predicts virulence, but highlighting complex interactions among effector proteins.
14 citationstop 1% - MicrobiologybioRxivPreprint
Differences between human and rodent nitric oxide production dictate susceptibility to tick-borne Rickettsia.
Anh Phuong Luu, Alejandro Amando Guzman, Alexis Bouin…·Thomas Burke
The paper identifies differences in nitric oxide production between human and rodent macrophages as a key factor in susceptibility to tick-borne Rickettsia.
- Cancer BiologyiSciencePeer-reviewed
Cytosolic bacterial pathogens activate TLR pathways in tumors that synergistically enhance STING agonist cancer therapies
Meggie Danielson, Christopher J. Nicolai, Thaomy T Vo…·Thomas Burke
This study shows that combining STING and TLR agonists enhances anti-tumor effects in mice, with synergistic responses observed when using bacterial pathogens and small molecule TLR agonists.
8 citations